1. Home
  2. TVTX vs TASK Comparison

TVTX vs TASK Comparison

Compare TVTX & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • TASK
  • Stock Information
  • Founded
  • TVTX 2008
  • TASK 2008
  • Country
  • TVTX United States
  • TASK United States
  • Employees
  • TVTX N/A
  • TASK N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • TASK Retail: Computer Software & Peripheral Equipment
  • Sector
  • TVTX Health Care
  • TASK Technology
  • Exchange
  • TVTX Nasdaq
  • TASK Nasdaq
  • Market Cap
  • TVTX 1.5B
  • TASK 1.5B
  • IPO Year
  • TVTX N/A
  • TASK 2021
  • Fundamental
  • Price
  • TVTX $24.64
  • TASK $17.25
  • Analyst Decision
  • TVTX Strong Buy
  • TASK Buy
  • Analyst Count
  • TVTX 16
  • TASK 4
  • Target Price
  • TVTX $35.20
  • TASK $16.88
  • AVG Volume (30 Days)
  • TVTX 2.7M
  • TASK 449.6K
  • Earning Date
  • TVTX 10-30-2025
  • TASK 11-06-2025
  • Dividend Yield
  • TVTX N/A
  • TASK N/A
  • EPS Growth
  • TVTX N/A
  • TASK 21.25
  • EPS
  • TVTX N/A
  • TASK 0.67
  • Revenue
  • TVTX $333,865,000.00
  • TASK $1,101,465,000.00
  • Revenue This Year
  • TVTX $83.87
  • TASK $19.10
  • Revenue Next Year
  • TVTX $40.99
  • TASK $11.73
  • P/E Ratio
  • TVTX N/A
  • TASK $25.99
  • Revenue Growth
  • TVTX 87.94
  • TASK 19.04
  • 52 Week Low
  • TVTX $12.91
  • TASK $10.57
  • 52 Week High
  • TVTX $28.69
  • TASK $19.60
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.38
  • TASK 40.59
  • Support Level
  • TVTX $23.22
  • TASK $17.74
  • Resistance Level
  • TVTX $25.10
  • TASK $17.94
  • Average True Range (ATR)
  • TVTX 1.27
  • TASK 0.25
  • MACD
  • TVTX -0.23
  • TASK -0.05
  • Stochastic Oscillator
  • TVTX 63.75
  • TASK 14.53

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About TASK TaskUs Inc.

TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.

Share on Social Networks: